feed,title,long_url,short_url
MedRxiv,"Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study",https://medrxiv.org/cgi/content/short/2022.12.28.22283666v1?rss=1,https://da.gd/ALSDc
